Research progress on the role of microglial glucose metabolism reprogramming in age-related macular degeneration_Chinese Journal of Ocular Fundus Diseases

Authors：

Zou Yue ^1,2,3 , Tan Xin ¹ ,  Li Yunqin ^1,2,3

1. Department of Ophthalmology, Affiliated Hospital of Yunnan University, Kunming 650021, China;
2. Yunnan Provincial Clinical Medical Center for Ophthalmic Diseases, Kunming 650021, China;
3. Yunnan Provincial Clinical Research Center for Eye Diseases, Kunming 650021, China;

Corresponding author：

Li Yunqin, Email: Liyunqin2004@126.com

Keywords：

Age-related macular degeneration; Microglial; Glucose metabolism reprogramming; Review

DOI：

10.3760/cma.j.cn511434-20240408-00147

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Age-related macular degeneration (AMD) involves dysregulation of the innate immune response of complement and mononuclear phagocytes and abnormalities of local microglia. When microglia transition from a resting state to an active state, their metabolic pathway also changes, known as "metabolic reprogramming", and their glucose metabolic reprogramming is a key factor in the pathogenesis of AMD, involving multiple signaling pathways. Including phosphatidylinositol 3-kinase-serine threonine kinase-rapamycin target, adenylate activated protein kinase and hypoxia-inducing factor 1 pathway. These metabolic changes regulate the inflammatory response, energy supply, and neuroprotective functions of microglia. Therapeutic strategies to regulate the reprogramming of glucose metabolism in microglia have achieved initial results. Future studies should further explore the mechanisms of microglia metabolic regulation to develop new targeted drugs and intervene in the treatment of AMD through anti-cellular aging pathways.

Citation： Zou Yue, Tan Xin, Li Yunqin. Research progress on the role of microglial glucose metabolism reprogramming in age-related macular degeneration. Chinese Journal of Ocular Fundus Diseases, 2024, 40(10): 819-824. doi: 10.3760/cma.j.cn511434-20240408-00147 Copy

1.
2.	Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis[J/OL]. Lancet Glob Health, 2014, 2(2): e106-e116[2014-01-03]. https://pubmed.ncbi.nlm.nih.gov/25104651/. DOI: 10.1016/S2214-109X(13)70145-1.
3.
4.	Akhtar-Schäfer I, Wang L, Krohne TU, et al. Modulation of three key innate immune pathways for the most common retinal degenerative diseases[J/OL]. EMBO Mol Med, 2018, 10(10): e8259[2018-10-01]. https://pubmed.ncbi.nlm.nih.gov/30224384/. DOI: 10.15252/emmm.201708259.
5.
6.	Au NPB, Ma CHE. Neuroinflammation, microglia and implications for retinal ganglion cell survival and axon regeneration in traumatic optic neuropathy[J/OL]. Front Immunol, 2022, 13: 860070[2022-04-04]. https://pubmed.ncbi.nlm.nih.gov/35309305/. DOI: 10.3389/fimmu.2022.860070.
7.
8.
9.
10.	Wang Q, Lu M, Zhu X, et al. The role of microglia immunometabolism in neurodegeneration: focus on molecular determinants and metabolic intermediates of metabolic reprogramming[J/OL]. Biomed Pharmacother, 2022, 153: 113412[2022-07-14]. https://pubmed.ncbi.nlm.nih.gov/36076537/. DOI: 10.1016/j.biopha.2022.113412.
11.	Guo L, Choi S, Bikkannavar P, et al. Microglia: key players in retinal ageing and neurodegeneration[J/OL]. Front Cell Neurosci, 2022, 16: 804782[2022-03-17]. https://pubmed.ncbi.nlm.nih.gov/35370560/. DOI: 10.3389/fncel.2022.804782.
12.	Wang C, Zong S, Cui X, et al. The effects of microglia-associated neuroinflammation on Alzheimer's disease[J/OL]. Front Immunol, 2023, 14: 1117172[2023-02-22]. https://pubmed.ncbi.nlm.nih.gov/36911732/. DOI: 10.3389/fimmu.2023.1117172.
13.
14.
15.	Spittau B. Aging microglia-phenotypes, functions and implications for age-related neurodegenerative diseases[J/OL]. Front Aging Neurosci, 2017, 9: 194[2017-06-14]. https://pubmed.ncbi.nlm.nih.gov/28659790/. DOI: 10.3389/fnagi.2017.00194.
16.
17.
18.
19.
20.
21.
22.
23.	Willmann C, Brockmann K, Wagner R, et al. Insulin sensitivity predicts cognitive decline in individuals with prediabetes[J/OL]. BMJ Open Diabetes Res Care, 2020, 8(2): e001741[2020-11-01]. https://pubmed.ncbi.nlm.nih.gov/33203727/. DOI: 10.1136/bmjdrc-2020-001741.
24.	Yu C, Lad EM, Mathew R, et al. Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2[J/OL]. J Exp Med, 2024, 221(3): e20231011[2024-03-04]. https://pubmed.ncbi.nlm.nih.gov/38289348/. DOI: 10.1084/jem.20231011.
25.
26.
27.
28.
29.
30.
31.
32.	Zhang S, Lachance BB, Mattson MP, et al. Glucose metabolic crosstalk and regulation in brain function and diseases[J/OL]. Prog Neurobiol, 2021, 204: 102089[2021-06-10]. https://pubmed.ncbi.nlm.nih.gov/34118354/. DOI: 10.1016/j.pneurobio.2021.102089.
33.	Lauro C, Limatola C. Metabolic reprograming of microglia in the regulation of the innate inflammatory response[J/OL]. Front Immunol, 2020, 11: 493[2020-03-20]. https://pubmed.ncbi.nlm.nih.gov/32265936/. DOI: 10.3389/fimmu.2020.00493.
34.	Lauro C, Chece G, Monaco L, et al. Fractalkine modulates microglia metabolism in brain ischemia[J/OL]. Front Cell Neurosci, 2019, 13: 414[2019-09-13]. https://pubmed.ncbi.nlm.nih.gov/31607865/. DOI: 10.3389/fncel.2019.00414.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.	Fairley LH, Wong JH, Barron AM. Mitochondrial regulation of microglial immunometabolism in Alzheimer’s disease[J/OL]. Front Immunol, 2021, 12: 624538[2021-02-25]. https://pubmed.ncbi.nlm.nih.gov/33717134/. DOI: 10.3389/fimmu.2021.624538.
46.	Chen H, Guo Z, Sun Y, et al. The immunometabolic reprogramming of microglia in Alzheimer’s disease[J/OL]. Neurochem Int, 2023, 171: 105614[2023-09-23]. https://pubmed.ncbi.nlm.nih.gov/37748710/. DOI: 10.1016/j.neuint.2023.105614.
47.
48.
49.
50.	Wang Y, Han S, Chen J, et al. PFKFB3 knockdown attenuates amyloid β-induced microglial activation and retinal pigment epithelium disorders in mice[J/OL]. Int Immunopharmacol, 2023, 115: 109691[2023-01-11]. https://pubmed.ncbi.nlm.nih.gov/36638665/. DOI: 10.1016/j.intimp.2023.109691.
51.
52.
53.
54.
55.
56.
57.	Ibuki M, Lee D, Shinojima A, et al. Rice bran and vitamin B6 suppress pathological neovascularization in a murine model of age-related macular degeneration as novel HIF inhibitors[J/OL]. Int J Mol Sci, 2020, 21(23): 8940[2020-11-25]. https://pubmed.ncbi.nlm.nih.gov/33255657/. DOI: 10.3390/ijms21238940.
58.	Lin FL, Cheng YW, Chen LH, et al. Retinal protection by fungal product theissenolactone B in a sodium iodate-induced AMD model through targeting retinal pigment epithelial matrix metalloproteinase-9 and microglia activity[J/OL]. Biomed Pharmacother, 2023, 158: 114138[2022-12-17]. https://pubmed.ncbi.nlm.nih.gov/36535199/. DOI: 10.1016/j.biopha.2022.114138.
59.	Sghaier R, Perus M, Cornebise C, et al. Resvega, a nutraceutical preparation, affects NFκB pathway and prolongs the anti-VEGF effect of bevacizumab in undifferentiated ARPE-19 retina cells[J/OL]. Int J Mol Sci, 2022, 23(19): 11704[2022-10-03]. https://pubmed.ncbi.nlm.nih.gov/36233006/. DOI: 10.3390/ijms231911704.
60.
61.

1.
2. Wong WL, Su X, Li X, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis[J/OL]. Lancet Glob Health, 2014, 2(2): e106-e116[2014-01-03]. https://pubmed.ncbi.nlm.nih.gov/25104651/. DOI: 10.1016/S2214-109X(13)70145-1.
3.
4. Akhtar-Schäfer I, Wang L, Krohne TU, et al. Modulation of three key innate immune pathways for the most common retinal degenerative diseases[J/OL]. EMBO Mol Med, 2018, 10(10): e8259[2018-10-01]. https://pubmed.ncbi.nlm.nih.gov/30224384/. DOI: 10.15252/emmm.201708259.
5.
6. Au NPB, Ma CHE. Neuroinflammation, microglia and implications for retinal ganglion cell survival and axon regeneration in traumatic optic neuropathy[J/OL]. Front Immunol, 2022, 13: 860070[2022-04-04]. https://pubmed.ncbi.nlm.nih.gov/35309305/. DOI: 10.3389/fimmu.2022.860070.
7.
8.
9.
10. Wang Q, Lu M, Zhu X, et al. The role of microglia immunometabolism in neurodegeneration: focus on molecular determinants and metabolic intermediates of metabolic reprogramming[J/OL]. Biomed Pharmacother, 2022, 153: 113412[2022-07-14]. https://pubmed.ncbi.nlm.nih.gov/36076537/. DOI: 10.1016/j.biopha.2022.113412.
11. Guo L, Choi S, Bikkannavar P, et al. Microglia: key players in retinal ageing and neurodegeneration[J/OL]. Front Cell Neurosci, 2022, 16: 804782[2022-03-17]. https://pubmed.ncbi.nlm.nih.gov/35370560/. DOI: 10.3389/fncel.2022.804782.
12. Wang C, Zong S, Cui X, et al. The effects of microglia-associated neuroinflammation on Alzheimer's disease[J/OL]. Front Immunol, 2023, 14: 1117172[2023-02-22]. https://pubmed.ncbi.nlm.nih.gov/36911732/. DOI: 10.3389/fimmu.2023.1117172.
13.
14.
15. Spittau B. Aging microglia-phenotypes, functions and implications for age-related neurodegenerative diseases[J/OL]. Front Aging Neurosci, 2017, 9: 194[2017-06-14]. https://pubmed.ncbi.nlm.nih.gov/28659790/. DOI: 10.3389/fnagi.2017.00194.
16.
17.
18.
19.
20.
21.
22.
23. Willmann C, Brockmann K, Wagner R, et al. Insulin sensitivity predicts cognitive decline in individuals with prediabetes[J/OL]. BMJ Open Diabetes Res Care, 2020, 8(2): e001741[2020-11-01]. https://pubmed.ncbi.nlm.nih.gov/33203727/. DOI: 10.1136/bmjdrc-2020-001741.
24. Yu C, Lad EM, Mathew R, et al. Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2[J/OL]. J Exp Med, 2024, 221(3): e20231011[2024-03-04]. https://pubmed.ncbi.nlm.nih.gov/38289348/. DOI: 10.1084/jem.20231011.
25.
26.
27.
28.
29.
30.
31.
32. Zhang S, Lachance BB, Mattson MP, et al. Glucose metabolic crosstalk and regulation in brain function and diseases[J/OL]. Prog Neurobiol, 2021, 204: 102089[2021-06-10]. https://pubmed.ncbi.nlm.nih.gov/34118354/. DOI: 10.1016/j.pneurobio.2021.102089.
33. Lauro C, Limatola C. Metabolic reprograming of microglia in the regulation of the innate inflammatory response[J/OL]. Front Immunol, 2020, 11: 493[2020-03-20]. https://pubmed.ncbi.nlm.nih.gov/32265936/. DOI: 10.3389/fimmu.2020.00493.
34. Lauro C, Chece G, Monaco L, et al. Fractalkine modulates microglia metabolism in brain ischemia[J/OL]. Front Cell Neurosci, 2019, 13: 414[2019-09-13]. https://pubmed.ncbi.nlm.nih.gov/31607865/. DOI: 10.3389/fncel.2019.00414.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45. Fairley LH, Wong JH, Barron AM. Mitochondrial regulation of microglial immunometabolism in Alzheimer’s disease[J/OL]. Front Immunol, 2021, 12: 624538[2021-02-25]. https://pubmed.ncbi.nlm.nih.gov/33717134/. DOI: 10.3389/fimmu.2021.624538.
46. Chen H, Guo Z, Sun Y, et al. The immunometabolic reprogramming of microglia in Alzheimer’s disease[J/OL]. Neurochem Int, 2023, 171: 105614[2023-09-23]. https://pubmed.ncbi.nlm.nih.gov/37748710/. DOI: 10.1016/j.neuint.2023.105614.
47.
48.
49.
50. Wang Y, Han S, Chen J, et al. PFKFB3 knockdown attenuates amyloid β-induced microglial activation and retinal pigment epithelium disorders in mice[J/OL]. Int Immunopharmacol, 2023, 115: 109691[2023-01-11]. https://pubmed.ncbi.nlm.nih.gov/36638665/. DOI: 10.1016/j.intimp.2023.109691.
51.
52.
53.
54.
55.
56.
57. Ibuki M, Lee D, Shinojima A, et al. Rice bran and vitamin B6 suppress pathological neovascularization in a murine model of age-related macular degeneration as novel HIF inhibitors[J/OL]. Int J Mol Sci, 2020, 21(23): 8940[2020-11-25]. https://pubmed.ncbi.nlm.nih.gov/33255657/. DOI: 10.3390/ijms21238940.
58. Lin FL, Cheng YW, Chen LH, et al. Retinal protection by fungal product theissenolactone B in a sodium iodate-induced AMD model through targeting retinal pigment epithelial matrix metalloproteinase-9 and microglia activity[J/OL]. Biomed Pharmacother, 2023, 158: 114138[2022-12-17]. https://pubmed.ncbi.nlm.nih.gov/36535199/. DOI: 10.1016/j.biopha.2022.114138.
59. Sghaier R, Perus M, Cornebise C, et al. Resvega, a nutraceutical preparation, affects NFκB pathway and prolongs the anti-VEGF effect of bevacizumab in undifferentiated ARPE-19 retina cells[J/OL]. Int J Mol Sci, 2022, 23(19): 11704[2022-10-03]. https://pubmed.ncbi.nlm.nih.gov/36233006/. DOI: 10.3390/ijms231911704.
60.
61.

Previous Article
Research progress on the mechanism and potential treatment of oxidative stress in diabetic retinal neurodegeneration

Chinese Journal of Ocular Fundus Diseases

Research progress on the role of microglial glucose metabolism reprogramming in age-related macular degeneration

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content